Home » Topics » Disease categories and therapies » Immune

Immune
RSS

The Ig FLC antagonist F-991 shows promise for contact allergy

Sep. 6, 2004

Immunomodulatory effects of alpha-MSH in preclinical models of allergy and hypersensitivity

Sep. 6, 2004

Vertex claims new SHP-2 phosphatase inhibitors and their use

Sep. 3, 2004

Vaccine programs progress at Sinovac

Sep. 2, 2004

MedImmune terminates rheumatoid arthritis and psoriasis trials for Vitaxin

Sep. 2, 2004

New S1P1/Edg1 agonists developed by Merck scientists

Sep. 2, 2004

Approvable letter for Certican

Sep. 1, 2004

New triptolide derivatives and their use reported by Pharmagenesis researchers

Aug. 30, 2004

Vertex researchers claim two series of heterocyclic inhibitors of JAK3 and other kinases

Aug. 25, 2004

New inhibitors of ICAM-1/LFA-1-mediated cell adhesion and their use

Aug. 24, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 7, 2026.
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.